Merck's Keytruda Combined with Chemoradiotherapy Gets FDA Approval to Treat Cervical Cancer

 Merck received approval from the Food and Drug Administration for cancer drug Keytruda in combination with chemoradiotherapy as a treatment for patients with FIGO 2014 Stage III-IVA cervical cancer.

The healthcare company said the approval marks the third indication for keytruda in cervical cancer and the 39th indication for keytruda in the United States.

https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-s-Keytruda-Combined-with-Chemoradiotherapy-Gets-FDA-Approval-to-Treat-Cervical-Cancer-45734920/